Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Caris Life SciencesCAI -0.89%11 Days Inventory is 85.31 as of Mar. 2026, which is 14% above its 10-year median of 75.00. GuruFocus rates CAI with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, Caris Life Sciences ranks better than 81.03% on this metric.
The historical rank and industry rank for Caris Life Sciences's Days Inventory or its related term are showing as below:
CAI'
s Days Inventory Range Over the Past 10 Years
Min: 68.51 Med: 75 Max: 96.04
Current: 68.51
During the past 4 years, Caris Life Sciences's highest Days Inventory was 96.04. The lowest was 68.51. And the median was 75.00.
CAI's Days Inventory is ranked better than 81.03% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs CAI: 68.51
Caris Life Sciences's Days Inventory
increased
from Mar. 2025 (54.39) to Mar. 2026 (85.31).
It might indicate that Caris Life Sciences's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Caris Life Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.07.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Caris Life Sciences's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.32.
Caris Life Sciences (NAS:CAI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Caris Life Sciences's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Caris Life Sciences's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Caris Life Sciences Days Inventory Related Terms
Caris Life Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Caris Life Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAI vs DNTH, MANE, TNGX: Days Inventory Comparison
For the Biotechnology subindustry, Caris Life Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Caris Life Sciences Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Caris Life Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Caris Life Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Caris Life Sciences (CAI) has a Days Inventory of 85.31 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Caris Life Sciences and its competitors. This is 14% above median its historical median of 75.00. Over the past decade, Caris Life Sciences' Days Inventory has ranged from 68.51 to 96.04. According to the industry distribution chart, Caris Life Sciences ranks #121 out of 638 companies in the Biotechnology industry, placing it in the top 19%.
Is Caris Life Sciences' Days Inventory too high?
Caris Life Sciences' current Days Inventory of 85.31 is 14% above median its 10-year median of 75.00. Over the past 10 years, this metric has ranged from a low of 68.51 to a high of 96.04. The Biotechnology industry median Days Inventory is 183.20. Caris Life Sciences' value of 85.31 is 53.4% below this industry median. Based on the distribution chart, Caris Life Sciences ranks #121 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Caris Life Sciences has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Caris Life Sciences' Days Inventory compare to DNTH and MANE?
According to the Biotechnology industry distribution chart, Caris Life Sciences ranks #121 out of 638 companies for Days Inventory. This places Caris Life Sciences in the top 19% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.20. Caris Life Sciences' value of 85.31 is 53.4% below this benchmark. Historically, Caris Life Sciences' own Days Inventory has ranged from 68.51 to 96.04 over the past decade. While the company's 10-year median is 75.00 vs. the industry median of 183.20, Caris Life Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Caris Life Sciences's current Days Inventory of 85.31 is 53.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Caris Life Sciences and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Caris Life Sciences's current Days Inventory is 85.31, which is 14% above median its own 10-year median of 75.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caris Life Sciences stock overvalued right now?
Caris Life Sciences (CAI) has a current Days Inventory of 85.31. The current Days Inventory is 85.31, which is 14% above median its 10-year median of 75.00 and 53.4% below the Biotechnology industry median of 183.20. Caris Life Sciences' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Caris Life Sciences (CAI), the current Days Inventory is 85.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
11GF Score
Get the complete analysis for CAI
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI has been successfully added to your 
